恒远药业 (838949.OC)

+ 收藏

利润表(恒远药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 56,483,927.68103,829,177.7155,099,680.76110,998,745.6853,803,972.68
 营业收入(元) 56,483,927.68103,829,177.7155,099,680.76110,998,745.6853,803,972.68
二、营业总成本(元) 43,513,287.7186,800,426.3543,058,705.3586,382,305.5442,821,328.40
 营业成本(元) 34,648,659.3267,830,268.4836,226,367.3473,272,432.4335,544,435.20
 研发费用(元) 3,353,298.1110,244,104.281,998,491.134,510,488.272,824,431.65
 营业税金及附加(元) 789,917.891,732,266.50922,288.991,639,740.42722,727.01
 销售费用(元) 19,142.3335,611.8517,674.2311,864.02230,161.69
 管理费用(元) 4,807,877.267,569,125.344,253,843.237,747,184.833,967,984.15
 财务费用(元) -105,607.20-610,950.10-359,959.57-799,404.43-468,411.30
  其中:利息费用(元) 55.796,198.47498.472,722.222,722.22
  其中:利息收入(元) 109,865.22624,249.17364,834.14809,575.88475,143.51
三、其他经营收益
 资产处置收益(元) --78,595.53--179,773.74-
 资产减值损失(元) -43,264.8736,812.20-65,838.34144,521.37-59,065.18
 信用减值损失(元) -115,019.7575,756.25119,601.50-326,001.50222,000.00
 其他收益(元) 562,615.453,209,224.991,896,750.002,839,394.111,181,144.11
四、营业利润(元) 13,374,970.8020,271,949.2713,991,488.5727,094,580.3812,326,723.21
五、利润总额(元) 13,374,970.8020,271,949.2713,991,488.5727,094,580.3812,326,723.21
 减:所得税费用(元) 1,694,492.021,307,431.431,715,857.953,370,861.131,427,339.92
六、净利润(元) 11,680,478.7818,964,517.8412,275,630.6223,723,719.2510,899,383.29
(一)按经营持续性分类
  持续经营净利润(元) -18,964,517.8412,275,630.6223,723,719.25-
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 11,680,478.7818,964,517.8412,275,630.6223,723,719.2510,899,383.29
 扣除非经常性损益后的净利润(元) 11,393,178.7816,303,482.8010,663,393.1221,463,041.949,895,410.80
七、每股收益
 一、基本每股收益(元) 0.230.370.240.460.21
 二、稀释每股收益(元) 0.230.310.240.460.21
九、综合收益总额(元) 11,680,478.7818,964,517.8412,275,630.6223,723,719.2510,899,383.29
 归属于母公司所有者的综合收益总额(元) 11,680,478.7818,964,517.8412,275,630.6223,723,719.2510,899,383.29
公告日期 2024-08-202024-04-162023-08-152023-04-132022-08-17
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院